Development demonstrates improved delivery of donepezil hydrochloride in models of Alzheimer's disease, suggesting novel therapeutic pathways.
Donepezil hydrochloride (DPZ) is an USFDA-approved selective and non-competitive centrally-acting acetylcholinesterase inhibitor used for the clinical management of dementia associated with mild-to-moderate Alzheimer’s disease (AD). However, treatment with DPZ is...
No takes yet. Share an insight, caveat, or question.
Suthar et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: